Mario J. Verdolini
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/16230_verdolin_2.jpg?itok=5hYkRPL3)
Filters
Century Aluminum $250 million senior secured notes offering and tender offer
Davis Polk advised the representative of the several initial purchasers in connection with Century Aluminum Company’s offering of 12.000% senior secured notes due 2025 in the aggregate…
Magenta Therapeutics $69 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $69 million follow-on offering of common stock of Magenta Therapeutics…
Digicel exchange offers and chapter 15 Bermuda scheme of arrangement recognition
We are advising Digicel in connection with the transactions
General Motors Financial $2 billion senior notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by General Motors Financial Company, Inc. of its $1.25 billion aggregate principal amount of 2.750% senior…
Equinix $2.6 billion senior notes offering
Davis Polk advised Equinix, Inc. on an SEC-registered offering of $2.6 billion aggregate principal amount of senior notes. The offering consisted of $500 million aggregate principal amount…
SiTime $128.8 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a follow-on offering of 4,025,000 shares of common stock of SiTime…
Mohawk Capital Finance €500 million notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Mohawk Capital Finance S.A. of fixed-rate notes due 2027. The notes are fully and unconditionally…
Westlake Chemical $300 million notes offering
Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Westlake Chemical Corporation of $300 million aggregate principal amount of its 3.375%…
Arco Platform $265.4 million secondary offering
Davis Polk advised Arco Platform Limited in connection with an SEC-registered secondary offering of 5,603,203 Class A common shares by certain selling shareholders at a price per Class A…
Atara Biotherapeutics $175 million stock and pre-funded warrants offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…